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Wednesday, February 19, 2014 777aresponses detected in non-lipid raft domains were more sensitive to direct
stimulation of AC activity with forskolin. Computational modeling suggests
that AC activity may play a more important role in explaining the compartmen-
talized responses observed in HEK293 cells, while PDE activity may be more
important in cardiac myocytes.
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In nonfailing mouse RV, a1-adrenergic receptors (a1-ARs) mediate a negative
inotropic effect (NIE). We reported that a1-AR inotropy in heart failure was
dramatically switched to a positive inotropic effect (PIE). The two predominant
a1-AR subtypes in heart are the a1A and a1B. However, their inotropic roles in
heart failure are unclear.
Goal: Determine the roles of a1A and a1B subtypes in upregulation of a1-AR
inotropy in failing RV.
Methods:We used a mouse model of bleomycin-induced RV failure. Bleomy-
cin or saline was instilled into the trachea. Using RV cardiac trabeculae, we
assessed in-vitro a1-AR inotropic responses to non-subtype selective agonist
phenylephrine (PE, stimulates a1A and a1B subtypes), or subtype-selective
agonist A61603 (stimulates only a1A subtype).
Results: Two wk after bleomycin, there was pulmonary fibrosis, pulmonary
hypertension and RV failure. For non-failing RV, A61603 caused a NIE (force
decreased 48510%, n=3) similar to the NIE mediated by PE (force decreased
52512%, n=3). Thus, stimulation of the a1A subtype singly, or together with
the a1B subtype, produced a similar NIE. In contrast, for failing RV, stimula-
tion with A61603 caused a switch to a PIE (force increased 134536%, n=7;
P<0.05). However, the PIE mediated by PE was much lower (force increased
34514%, n=7; P<0.05). Thus, stimulation of the a1A subtype singly produced
a much greater inotropic response versus stimulation of both a1A and a1B
subtypes. This suggests that upregulation of a1-AR inotropy in the failing
RV was mediated by the a1A subtype, but opposed by the a1B subtype. Pre-
liminary studies suggest a role for myosin light chain kinase in upregulation
of a1-AR inotropy in failing RV.
Conclusion: The switch to a PIE induced by a1-ARs in failing RV is mediated
by the a1A subtype, not the a1B subtype.
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Normal cardiac function declines with age, and a major contributor to heart
failure is diastolic dysfunction. The causes of diastolic dysfunction are not
yet fully known, although perturbations that affect cardiomyocyte passive
mechanics, or stiffness, and calcium handling have been implicated. Here,
we have studied the effect of aging on cardiac dysfunction and myocardial
stiffening in Drosophila melanogaster, an ideal model for studying senescence
due to its short lifespan and ease of genetic manipulation. The transcription
factor FOXO, a member of the insulin signaling pathway family shown to
mediate an extensive variety of cellular responses in humans, has also been
shown to promote general muscle proteostasis and, more specifically, improve
cardiac performance following pacing-induced stress in Drosophila. In this
study, using high-speed video microscopy and motion analysis, we measured
a significant decrease in heart rate and diastolic diameter and increased
arrhythmic beating patterns in control fly hearts with age. These changes
suggest senescent-related decreases in cardiac output. Furthermore, using an
atomic force microscopy-based nanoindentation approach, we determined
that control hearts underwent age-related transverse stiffening. Overexpression
of FOXO in a heart-specific manner ameliorated these effects as indicated by a
lower incidence of arrhythmias, elevated heart rate and increased diastolic
diameter with age as well as by affording protection against age-related
changes in transverse myocardial stiffness. These data support the hypothesis
that increased FOXO activity helps maintain muscle proteostasis in aging
hearts. Because aberrant calcium homeostasis in cardiomyocytes may
contribute to diastolic dysfunction, we are also interested in evaluating possible
cardioprotective effects of FOXO overexpression on calcium handling in aging
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Myosin storage myopathy (MSM) is a congenital disorder caused by dominant
missense mutations in the b-cardiac MHC rod and characterized by subsarco-
lemmal accumulation of b-cardiac myosin that has a hyaline appearance. These
mutations map near to or within the assembly competence domain known to be
crucial to filament assembly. Themutations disrupt hydropathy or charge of res-
idues in the heptad repeat, altering interactions that stabilize myosin coiled-coil
dimers and thick filaments. This potentially disrupts orderedmyofibrillar assem-
bly, causing myofibrillar disarray and myosin aggregation. Our Drosophila
models for MSM make it possible to examine interactions between wild-type
and mutant full-length myosins for pursuing mechanistic investigations. We
introduced the R1845W, L1793P or the E1883K mutation into a Drosophila
MHC transgene and expressed each in the indirect flight/jump muscles and in
the heart. Our studies show a severe reduction in the flight and jump ability of
the transgenic flies in both homozygous and heterozygous states, with an age-
dependent worsening of muscle function. Electron and confocal microscopy
of the indirect flight muscles of transgenic lines show myofibrillar disarray
with large areas of granular/ filamentous inclusions similar to hyaline bodies
found in affected humans. Semi-automated optical heartbeat analysis of the
mutant heterozygotes shows restrictive cardiac physiology and diastolic
dysfunction with evidence of worsening cardiac phenotype with age. Lifespans
of the MSM mutants are also reduced in comparison to the transgenic control.
Future studies will aim at analyzing in vitro filament forming ability of the
mutant myosin to determine if defective filament formation and/or instability
of the myosin filaments are the basis of MSM. Our model would also potentially
help discern if specific chaperones, small molecule chaperone inducers or
enhanced autophagy can ameliorate myopathic defects in MSM.
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Familial hypertrophic cardiomyopathy (FHC) is a genetic disease of the heart
muscle that can be caused by mutations in sarcomeric proteins such as cardiac
troponin T (TnT), a thin filament regulator of muscle contraction. Results from
our lab show that the ubiquitin proteasome system (UPS) is affected in TnT-
related cardiomyopathies; in FHC mice expressing the I79N or R278C mutant
forms of TnT, changes in proteasome subunit expression and gene expression
of proteins in the ubiquitination pathway, increased levels of oxidized proteins,
and decreases in proteasome activity in 3 month old I79N mice were observed,
suggesting that UPS dysfunction may be an important contributing factor to the
pathogenesis of this disease. Mutations in sarcomeric proteins can alter their
rates of proteasomal degradation, and increased degradation may lead to pro-
teasome functional insufficiency by competitively inhibiting breakdown of
other proteasome substrates. To investigate whether the observed impairment
of proteasome function was due to a change in the degradation rate of mutated
TnT, the degradation rates of wild-type and mutated (I79N and R278C) TnT
were determined in CV-1 cells. The half-life of TnT was not affected by either
mutation, suggesting that the effects of these mutations on the proteasome are
not due to a difference in the degradation rate of TnT. Experiments to determine
the rate of degradation of the FHCmutant F110I are currently being carried out.
Overall, our results suggest that the effects of FHC mutations on proteasome
function are not due to the mutation directly affecting the proteasome. This
work was supported by NIH Grant HL096819.
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NAD(P)H oxidases (NOXs) are of one the major sources of ROS in heart.
Recently we reported that NOX2-mediated oxidative stress drives the develop-
ment of cellular phenotype of cardiac dystrophy. Here we investigated the role
of miRNAs in upregulation of NOX2 gene expression. Initial screening with
a microRNA target prediction on-line database identified a number of
microRNAs that are potential regulators of NOX2 genes. Following qRT-PCR
screening of these microRNAs showed a drastic 10-fold down-regulation of
778a Wednesday, February 19, 2014miR-448 in hearts of young dystrophic mice. The latter correlated with overex-
pression of the Ncf1 gene, encoding the NOX2 regulatory subunit p47phox.
Specificity of Ncf1 targeting by miR-448 was confirmed by luciferase reporter
assay. To study the effect of miR-448 silencing on molecular, cellular and func-
tional properties of normal hearts, we intravenously injectedwild typemicewith
LNA-NC and LNA-miR-448 inhibitors. qRT-PCR, western blotting, confocal
imaging of ROS and intracellular Ca2þ signals and echocardiography were em-
ployed. Acute inhibition of miR-448 resulted in an increase in Ncf1 expression
aswell as enhancedROSproduction and augmented intracellular Ca2þ signaling
in isolated cardiomyocytes. In addition, prolong (over one month) inhibition of
miR-448 led to the deterioration of cardiac functions and development of dilated
cardiomyopathy and arrhythmia. Overall, WT mice with inhibited miR-448
mimicked many features of dystrophic cardiomyopathy. Our data suggest that
downregulation of miR-448 relieves inhibition of translational initiation of
Ncf1 in dystrophic cardiomyopathy. It results in an increase in Ncf1 expression
and consequently in oxidative stress and enhanced Ca2þ signaling in dystrophic
heart well before cardiac dysfunction becomes evident.
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Heart failure associated with chronic aging is underscored by altered expression
of actin-binding cytoskeletal molecules. How cytoarchitectural remodeling
impacts cardiac structure and contractile function remains unclear. We have
developed novel biophysical techniques to interrogate subcellular mechanics
and cellular function in the genetically tractable, rapidly aging Drosophila, a
useful model for mammalian cardiac development. Genotype-dependent, age-
related remodeling was a conserved hallmark in wildtype flies signified by
decreased systolic and diastolic dimensions between 1 and 5 weeks of age.
Remodeling correlated with increased cortical stiffness, particularly at the inter-
calated disc (ID). Inhibition of actin polymerization reversed the stiffening
phenotype at the ID while inhibition of actomyosin crosslinking did not. Age-
related remodeling also correlated with preserved contractile function. In
contrast, non-remodeled hearts experienced impaired shortening velocities.
Cardiac-specific genetic perturbations were employed to determine how altered
expression of vinculin (Vcl) affected structure and function independent of
aging. Vcl overexpression resulted in increased localization to the ID, decreased
diastolic diameter, and increased cortical stiffness at 1wk of age preferentially at
the ID. However, fractional shortening and shortening velocity increased as
compared to controls, suggesting that muscle performance was not hindered
by Vcl-overexpression despite altered physiology. Vcl-overexpressing hearts
treated with cytochalasin D exhibited significant softening at the ID while
blebbistatin-treated flies did not, suggesting that Vcl induces stiffening through
actin recruitment. In contrast to current models that suggest that intercalated
disc remodeling may be maladaptive for age-related cardiac decline, no reduc-
tion in systolic function was observed in hearts with Vcl-overexpression. There-
fore, Vcl may play a key regulatory role in maintenance of cardiomyocyte
structure and function with age. Further studies will investigate the biophysical
mechanisms of increased shortening function due to Vcl-mediated remodeling
and identify upstream activators of Vcl-upregulation.
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The intercalated disc (ID) of cardiac muscle embodies a highly ordered,
multifunctional network, which is essential for the transmission of electrical
stimuli and mechanical force resulting in the synchronous contraction of the
heart. Recently, a plethora of proteins have been identified as novel components
of the ID. The challenge now lies in their characterization as it relates to the
mechanical and electrical coupling of neighbouring cardiomyocytes. Here
we focus on the molecular and functional description of one of these novel
members, obscurin-90.
Obscurins are a family of proteins expressed in striated muscles where they
localize to distinct subdomains, i.e. the sarcoplasmic reticulum, the sarcomeric
cytoskeleton, and the sarcolemma, and function in their assembly and integra-tion. Previous studies have shown that transcripts arising from the single
OBSCN gene are extensively spliced, resulting in several obscurin isoforms.
Complex splicing at its 3’ end gives rise to obscurin-90 (obsc90), the isoform
that preferentially localizes to the ID. Obsc90 contains tandem RhoGEF
and PH motifs, two Ig domains, and a non-modular COOH-terminus with
ankyrin-binding sites and ERK phosphorylation cassettes. Using immunofluo-
rescence and immunoelectron microscopy, we show that obsc90 localizes to the
ID, and specifically at the outer edge of the transition zone. Consistent with this,
biochemical assays demonstrated that obsc90 is in a complex with major ID
proteins, including N-cadherin, connexin-43, vinculin, and ankyrinG. Obsc90
is targeted to the ID through the direct binding of its PH domain to membrane
lipids, and its functions are likely regulated by phosphorylation of its COOH-
terminus. Preliminary evidence indicates that the phosphorylation profile of
obsc90 is altered in hypertrophic cardiomyopathy.. Further experiments are
underway to examine the function of obsc90 at the ID and its regulation via
phosphorylation in health and disease.
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The mechanism by which more thin filaments are built during cardiac hypertro-
phy is not fully understood. Very rapid increases the dynamics both actin and
the actin capping protein (CapZ) following mechanical flexing suggest that a
post-translational regulation is the underlying mechanism. Neonatal rat ventric-
ular myocytes in culture were stimulated to hypertrophy by a neurohormone
(10mM phenylephrine, PE, for 24 hr). CapZ dynamics were analyzed by fluo-
rescence recovery after photobleaching (FRAP) using CapZb1-GFP. After
PE treatment, CapZ dynamics increased above resting controls by ~3.17 fold
(p=0.0004). Post-translational modifications of CapZ were analyzed by 2D
gel electrophoresis. After PE treatment, 2D spots of CapZb1-GFP have an
increased negative shift, suggesting that post-translational modification of
CapZ is up regulated. To identify the types of post-translational modifications,
2D western blotting and mass spectrometry (MS) was applied. Increased post-
translational spots included the acetylation of K199 and phosphorylation of
S204, which are both close to the actin-binding region of CapZ. To test whether
CapZ acetylation was mediated by HDAC3, located at the Z-disc of myocytes,
the class I HDAC inhibitor (5mM trichostatin A / 5hr) and HDAC3 activator
(10mM theophylline / 24hr) were applied. CapZ dynamics with trichostatin
A increased by four-fold (p=0.01), and the effect of PE on CapZ dynamics
was blunted by theophylline (p=0.09). Thus, the increased sarcomere remodel-
ing during cardiac hypertrophy may be induced via altered acetylation of
CapZ, which is mediated by HDAC3. In addition to MS identification of
phosphorylation sites, post-translational modifications were reduced by domi-
nant negative PKC 3, suggesting a regulatory role. Together the acetyl and
phospho posttranslational modifications of CapZ reduce the capping property
and may increase thin filament assembly. NIH HL62426 (BR) and AHA
12PRE12050371 (Y-H L).
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Introduction: Hypertrophic cardiomyopathy(HCM) is frequently caused by
mutations in genes encoding sarcomeric proteins. Decreased force development
was found in human HCM due to mutations in genes encoding myosin binding
protein-C(MYBPC3), myosin heavy chain(MYH7) and in sarcomere mutation-
negative HCM(HCMsmn). This is partially caused by the mutation (especially
MYH7 mutations), increased cell size and reduced myofibrillar density. How-
ever, 10% force reduction could not be explained by the mutation or cellular re-
modeling. In end-stage human heart failure increased actin-carbonylation,
induced by oxidative stress, negatively correlated with myocardial function.
Therefore, we investigated whether actin is carbonylated in human HCM.
Methods and results: Left ventricular tissue of human HCMsmn, MYBPC3-
mut and MYH7mut patients was obtained. Non-failing donors were used
as control. Actin-carbonylation was analyzed using Oxyblot. Carbonyl
groups of myofilament proteins were derivatized by 2,4-dinitrophenyl-hydra-
zine(DNPH). Protein lysates were processed via SDS-page, western blot
